Newsroom | Galderma US

Galderma successfully completes acquisition of ALASTIN Skincare®

Galderma Receives FDA Approval for New SCULPTRA® Label, Offering More Options to Aesthetic Partners

Galderma announces relocation of U.S. Headquarters to downtown Dallas

Galderma to acquire award-winning ALASTIN Skincare® enhancing its integrated dermatology platform to continue delivering the best experience to patients

Galderma leads oral presentation on hyaluronic acid filler safety insights at ASDS 2021 Annual Meeting

RESTYLANE® celebrates 25 years of natural-looking results with its signature line of hyaluronic acid fillers

Galderma and CETAPHIL® Announce Renewed Commitment to Environmental Sustainability and Social Impact Through New Clear Skies Initiative

Galderma announces exclusive agreement with Sofregen to develop the next generation of biostimulator fillers using silk-based technology

Cetaphil® Announces Major Evolution in Brand’s Mission to Advance Sensitive Skin Science

Sol-Gel Technologies Announces FDA Approval of TWYNEO®

Galderma receives FDA approval for Restylane® Contour for cheek augmentation and correction of midface contour deficiencies

Sol-Gel Technologies and Galderma announce exclusive licenses for the commercialization of EPSOLAY® and TWYNEO® in the United States

Cetaphil® Champions Sun Protection Awareness and Education with Dermatologist-led Digital Campaign